Bausch Health Files 8-K on Operations & Financials

Ticker: BHC · Form: 8-K · Filed: Apr 30, 2025 · CIK: 885590

Sentiment: neutral

Topics: financial-reporting, operations

TL;DR

Bausch Health dropped an 8-K detailing its latest financials - check it for the real scoop.

AI Summary

Bausch Health Companies Inc. filed an 8-K on April 30, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. The filing details the company's operational and financial status as of the reporting date.

Why It Matters

This filing provides an update on Bausch Health's financial performance and operational status, which is crucial for investors to assess the company's current health and future prospects.

Risk Assessment

Risk Level: low — This is a routine 8-K filing providing standard financial and operational updates, not indicating any immediate or significant new risks.

Key Players & Entities

FAQ

What specific financial results are being reported in this 8-K?

The filing indicates it reports on 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific figures are not detailed in the provided text.

What is the exact date of the report?

The report is dated April 30, 2025.

What is the principal executive office address for Bausch Health Companies Inc.?

The principal executive offices are located at 2150 St. Elzéar Blvd. West, Laval, Québec, Canada H7L 4A8.

What is the IRS Employer Identification Number (EIN) for Bausch Health Companies Inc.?

The IRS Employer Identification Number is 98-0448205.

What were some of Bausch Health's former company names?

Bausch Health Companies Inc. was formerly known as Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, and BIOVAIL CORP INTERNATIONAL.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 30, 2025 regarding Bausch Health Companies Inc. (BHC).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing